These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 29095811)
1. Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis. Nambot S; Thevenon J; Kuentz P; Duffourd Y; Tisserant E; Bruel AL; Mosca-Boidron AL; Masurel-Paulet A; Lehalle D; Jean-Marçais N; Lefebvre M; Vabres P; El Chehadeh-Djebbar S; Philippe C; Tran Mau-Them F; St-Onge J; Jouan T; Chevarin M; Poé C; Carmignac V; Vitobello A; Callier P; Rivière JB; Faivre L; Thauvin-Robinet C; Genet Med; 2018 Jun; 20(6):645-654. PubMed ID: 29095811 [TBL] [Abstract][Full Text] [Related]
2. Reanalysis of whole-exome sequencing (WES) data of children with neurodevelopmental disorders in a standard patient care context. van Slobbe M; van Haeringen A; Vissers LELM; Bijlsma EK; Rutten JW; Suerink M; Nibbeling EAR; Ruivenkamp CAL; Koene S Eur J Pediatr; 2024 Jan; 183(1):345-355. PubMed ID: 37889289 [TBL] [Abstract][Full Text] [Related]
3. Reanalysis of whole exome sequencing data in patients with epilepsy and intellectual disability/mental retardation. Li J; Gao K; Yan H; Xiangwei W; Liu N; Wang T; Xu H; Lin Z; Xie H; Wang J; Wu Y; Jiang Y Gene; 2019 Jun; 700():168-175. PubMed ID: 30904718 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic exome sequencing in 100 consecutive patients with both epilepsy and intellectual disability. Snoeijen-Schouwenaars FM; van Ool JS; Verhoeven JS; van Mierlo P; Braakman HMH; Smeets EE; Nicolai J; Schoots J; Teunissen MWA; Rouhl RPW; Tan IY; Yntema HG; Brunner HG; Pfundt R; Stegmann AP; Kamsteeg EJ; Schelhaas HJ; Willemsen MH Epilepsia; 2019 Jan; 60(1):155-164. PubMed ID: 30525188 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of automated, streamlined, daily updated exome analysis in patients with neurodevelopmental delay. Seo GH; Lee H; Lee J; Han H; Cho YK; Kim M; Choi Y; Choi J; Choi IH; Rhie S; Chae KY; Kim YM; Cheon CK; Kim SJ; Lee J; Kang E; Byeon JH; Yu HJ; Shin YL; Oh A; Kim WJ; Yum MS; Lee BH; Eun BL Mol Med; 2022 Mar; 28(1):38. PubMed ID: 35346031 [TBL] [Abstract][Full Text] [Related]
6. Genetic and phenotypic analysis of 101 patients with developmental delay or intellectual disability using whole-exome sequencing. Hiraide T; Yamoto K; Masunaga Y; Asahina M; Endoh Y; Ohkubo Y; Matsubayashi T; Tsurui S; Yamada H; Yanagi K; Nakashima M; Hirano K; Sugimura H; Fukuda T; Ogata T; Saitsu H Clin Genet; 2021 Jul; 100(1):40-50. PubMed ID: 33644862 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test. Thevenon J; Duffourd Y; Masurel-Paulet A; Lefebvre M; Feillet F; El Chehadeh-Djebbar S; St-Onge J; Steinmetz A; Huet F; Chouchane M; Darmency-Stamboul V; Callier P; Thauvin-Robinet C; Faivre L; Rivière JB Clin Genet; 2016 Jun; 89(6):700-7. PubMed ID: 26757139 [TBL] [Abstract][Full Text] [Related]
8. Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders. Ewans LJ; Schofield D; Shrestha R; Zhu Y; Gayevskiy V; Ying K; Walsh C; Lee E; Kirk EP; Colley A; Ellaway C; Turner A; Mowat D; Worgan L; Freckmann ML; Lipke M; Sachdev R; Miller D; Field M; Dinger ME; Buckley MF; Cowley MJ; Roscioli T Genet Med; 2018 Dec; 20(12):1564-1574. PubMed ID: 29595814 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability. Monroe GR; Frederix GW; Savelberg SM; de Vries TI; Duran KJ; van der Smagt JJ; Terhal PA; van Hasselt PM; Kroes HY; Verhoeven-Duif NM; Nijman IJ; Carbo EC; van Gassen KL; Knoers NV; Hövels AM; van Haelst MM; Visser G; van Haaften G Genet Med; 2016 Sep; 18(9):949-56. PubMed ID: 26845106 [TBL] [Abstract][Full Text] [Related]
10. An efficient genetic test flow for multiple congenital anomalies and intellectual disability. Yokoi T; Enomoto Y; Tsurusaki Y; Harada N; Saito T; Nagai JI; Naruto T; Kurosawa K Pediatr Int; 2020 May; 62(5):556-561. PubMed ID: 31955471 [TBL] [Abstract][Full Text] [Related]
11. CoDE-seq, an augmented whole-exome sequencing, enables the accurate detection of CNVs and mutations in Mendelian obesity and intellectual disability. Montagne L; Derhourhi M; Piton A; Toussaint B; Durand E; Vaillant E; Thuillier D; Gaget S; De Graeve F; Rabearivelo I; Lansiaux A; Lenne B; Sukno S; Desailloud R; Cnop M; Nicolescu R; Cohen L; Zagury JF; Amouyal M; Weill J; Muller J; Sand O; Delobel B; Froguel P; Bonnefond A Mol Metab; 2018 Jul; 13():1-9. PubMed ID: 29784605 [TBL] [Abstract][Full Text] [Related]
12. The diagnostic yield of intellectual disability: combined whole genome low-coverage sequencing and medical exome sequencing. Wang J; Wang Y; Wang L; Chen WY; Sheng M BMC Med Genomics; 2020 May; 13(1):70. PubMed ID: 32429945 [TBL] [Abstract][Full Text] [Related]
13. Community-based recruitment and exome sequencing indicates high diagnostic yield in adults with intellectual disability. Sabo A; Murdock D; Dugan S; Meng Q; Gingras MC; Hu J; Muzny D; Gibbs R Mol Genet Genomic Med; 2020 Oct; 8(10):e1439. PubMed ID: 32767738 [TBL] [Abstract][Full Text] [Related]
14. Reverse Phenotyping after Whole-Exome Sequencing in Children with Developmental Delay/Intellectual Disability-An Exception or a Necessity? Ilic N; Maric N; Maver A; Armengol L; Kravljanac R; Cirkovic J; Krstic J; Radivojevic D; Cirkovic S; Ostojic S; Krasic S; Paripovic A; Vukomanovic V; Peterlin B; Maric G; Sarajlija A Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927725 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of partial exome sequencing in developmental disorders. Gieldon L; Mackenroth L; Kahlert AK; Lemke JR; Porrmann J; Schallner J; von der Hagen M; Markus S; Weidensee S; Novotna B; Soerensen C; Klink B; Wagner J; Tzschach A; Jahn A; Kuhlee F; Hackmann K; Schrock E; Di Donato N; Rump A PLoS One; 2018; 13(8):e0201041. PubMed ID: 30091983 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic yield of patients with undiagnosed intellectual disability, global developmental delay and multiples congenital anomalies using karyotype, microarray analysis, whole exome sequencing from Central Brazil. Leite AJDC; Pinto IP; Leijsten N; Ruiterkamp-Versteeg M; Pfundt R; de Leeuw N; da Cruz AD; Minasi LB PLoS One; 2022; 17(4):e0266493. PubMed ID: 35390071 [TBL] [Abstract][Full Text] [Related]
17. Increase in diagnostic yield achieved for 174 whole-exome sequencing cases reanalyzed 1-2 years after initial analysis. Liu Y; Teng Y; Li Z; Cui J; Liang D; Wu L Clin Chim Acta; 2021 Dec; 523():163-168. PubMed ID: 34560057 [TBL] [Abstract][Full Text] [Related]
18. Reduced resource utilization with early use of next-generation sequencing in rare genetic diseases in an Asian cohort. Nazeha N; Koh AL; Kam S; Lim JY; Goh DLM; Jamuar SS; Graves N Am J Med Genet A; 2022 Dec; 188(12):3482-3491. PubMed ID: 36156406 [TBL] [Abstract][Full Text] [Related]
19. Diagnosing rare diseases after the exome. Frésard L; Montgomery SB Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30559314 [TBL] [Abstract][Full Text] [Related]
20. Reanalysis of exome negative patients with rare disease: a pragmatic workflow for diagnostic applications. Schobers G; Schieving JH; Yntema HG; Pennings M; Pfundt R; Derks R; Hofste T; de Wijs I; Wieskamp N; van den Heuvel S; Galbany JC; Gilissen C; Nelen M; Brunner HG; Kleefstra T; Kamsteeg EJ; Willemsen MAAP; Vissers LELM Genome Med; 2022 Jun; 14(1):66. PubMed ID: 35710456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]